Escaping residual albuminuria in hypertension: should we start eplerenone or reduce salt intake?

Hypertens Res. 2019 Apr;42(4):583-585. doi: 10.1038/s41440-019-0214-x. Epub 2019 Jan 23.

Authors

Martin H de Borst¹, Gozewijn D Laverman², Gerjan Navis³

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. m.h.de.borst@umcg.nl.
² Department of Nephrology, Ziekenhuis Groep Twente (ZGT) Hospital, Almelo and Hengelo, The Netherlands.
³ Division of Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

PMID: 30675039
DOI: 10.1038/s41440-019-0214-x

No abstract available

Publication types

Editorial
Comment

MeSH terms

Albuminuria
Diabetes Mellitus*
Eplerenone
Humans
Hypertension*
Receptors, Mineralocorticoid
Sodium Chloride, Dietary
Spironolactone

Substances

Receptors, Mineralocorticoid
Sodium Chloride, Dietary
Spironolactone
Eplerenone